This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Bristol-Myers Squibb Company
Drug Names(s): BMS770767
Description: BMS-770767 is a proprietary compound with an undisclosed mechanism of action. Outcomes for its clinical trials suggests it is a 11ß-HSD1 (11 beta-hydroxysteroid dehydrogenase) inhibitor.
Additional information available to subscribers only: